ArticleAmerican journal of translational research2016

Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome.

Jun Yang et al.PubMed ↗Full text ↗

No numbers read from the abstract.